Published • loading... • Updated
RBL LLC Announces Launch of Sentinel BioTherapeutics at the 2025 ASCO Annual Meeting
Summary by Star Local
5 Articles
5 Articles
Star Local+4 Reposted by 4 other sources
RBL LLC Announces Launch of Sentinel BioTherapeutics at the 2025 ASCO Annual Meeting
Sentinel BioTherapeutics is a clinical-stage company developing innovative immune-priming therapies for the treatment of solid tumorsSafety data on Sentinel's lead asset to be presented in poster at the 2025 American Society of Clinical Oncology (ASCO) Annual MeetingCompany is the first…
Coverage Details
Total News Sources5
Leaning Left0Leaning Right1Center4Last UpdatedBias Distribution80% Center
Bias Distribution
- 80% of the sources are Center
80% Center
C 80%
R 20%
Factuality
To view factuality data please Upgrade to Premium
